Clinical Trial

Evaluation the Efficacy Between Botox Injection and Combination Pharmacotherapy in Patients With Detrusor Overactivity

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 9, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To investigates the effects of botulinum toxin type A bladder injection compared to combined pharmacotherapy with Mirabegron and Solifenacin.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-29; most recent amendment 2025-05-06.
Trial Details
NCT Number NCT05968885
Lead Sponsor Mackay Memorial Hospital
Conditions Urinary Bladder, Overactive, Urodynamics, Effect of Drug
Enrollment 300 participants
Start Date 2021-10-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-09